Has Rohit Kumar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,619,496 in general payments to Rohit Kumar, MD across 637 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rohit Kumar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rohit Kumar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rohit Kumar, MD

Hematology & Oncology · Louisville, KYNPI 1154737724

Payments from drug & device makers

$1,619,496in general payments, 2019–2025

Across 637 payments — averaging $2542.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$1.3M
Pfizer$155K
Eli Lilly$40K
Amgen$39K
Janssen Research & Development, LLC$32K
EMD Serono, Inc.$3K
plus $16K from 50 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	71	$1,334,107
Pfizer	62	$155,280
Eli Lilly	3	$40,132
Amgen	82	$39,203
Janssen Research & Development, LLC	5	$31,632
EMD Serono, Inc.	8	$2,985
AstraZeneca(2 entities)	20	$2,415
Springworks Therapeutics, Inc.	6	$2,367
Deciphera Pharmaceuticals Inc.	3	$1,144
Johnson & Johnson	31	$1,084
Daiichi Sankyo Inc.	43	$943
Eisai Inc.	24	$887
Bristol Myers Squibb	21	$827
Novartis	30	$659
E.r. Squibb & Sons, L.L.C.	36	$617
Novo Nordisk	1	$501
Astellas Pharma US Inc	11	$489
Bayer	16	$452
Incyte Corporation	22	$406
Jazz Pharmaceuticals Inc.	6	$400
Lilly USA, LLC	17	$370
Sanofi	16	$291
Regeneron Healthcare Solutions, Inc.	6	$222
Genentech USA, Inc.	4	$208
Rigel Pharmaceuticals, Inc.	6	$192
Sumitomo Pharma America, Inc.	9	$182
Seagen Inc.	10	$180
Exelixis Inc.	1	$122
AbbVie	6	$119
Stemline Therapeutics Inc.	6	$101
Gilead(2 entities)	5	$89
Boehringer Ingelheim	5	$82
Foundation Medicine, Inc.	5	$81
AVEO Pharmaceuticals, Inc.	5	$80
Takeda Pharmaceuticals U.S.A., Inc.	3	$60
Puma Biotechnology, Inc.	3	$55
Array Biopharma Inc	3	$50
Medivation Services LLC	1	$49
Ipsen Biopharmaceuticals, Inc	3	$46
Adaptive Biotechnologies Corporation	2	$45
Pharmacyclics LLC, An Abbvie Company	3	$41
Dova Pharmaceuticals	2	$37
Apellis Pharmaceuticals, Inc.	2	$32
Tersera Therapeutics LLC	1	$26
Verastem, Inc.	1	$24
Sun Pharmaceutical Industries Inc.	1	$23
Pharmaessentia USA Corporation	1	$21
CTI Biopharma Corp.	1	$19
Beigene USA, Inc.	1	$17
Taiho Oncology, Inc.	1	$16
Global Blood Therapeutics, Inc.	1	$16
Mirati Therapeutics, Inc.	1	$15
Recordati_rare_diseases_inc.	1	$15
ADC Therapeutics America, Inc.	1	$13
Karyopharm Therapeutics Inc.	1	$13
Immunomedics, Inc.	1	$13

How this compares

$1,619,496 in reported general payments places this provider in the 95th percentile of 143 hematology & oncology providers in Kentucky.

See all hematology & oncology providers in Kentucky →

Medicare billing

Part B allowed, 2024

$114,768

Medicare patients

284

Services billed

1,025

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Louisville

Joseph MalyLouisville$7M
Laila AgrawalLouisville$6.3M
Jaspreet GrewalLouisville$4.2M
Rebecca RedmanLouisville$2.1M
Vivek SharmaLouisville$1.9M
Jeffrey HargisLouisville$1.3M
Goetz KloeckerLouisville$1.2M
Elizabeth RileyLouisville$746K
Adam LyeLouisville$706K
Brian DongLouisville$664K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →